In the News

De La Rue and OPTEL Group announced a strategic partnership to address the growing threat of global counterfeiting.  De La Rue is the global leader in anti-counterfeit solutions as well as the world’s largest printer of both currency and passports.  OPTEL is the leading provider of end-to-end traceability...

Recently, OPTEL partnered with The Axia Institute to author an article about serialization data and the smarter supply chain for Pharma Horizon's January/February 2018 issue VOL. 2(1). This journal is focused on providing industry trends, marketing, market access, regulatory and compliance, and pharmaceutical development information to organizations that operate within...

Verify Brand's insights on using serialization data to prevent counterfeiting were recently featured in an online Lab Manager article, "How Analytical Methods are Helping Uncover Counterfeit Pesticides." The health and sciences publication reached out to Verify Brand's senior vice president of professional services, Curt Tomhave, regarding...

In August, Verify Brand's CEO, Michael Howe, wrote an article in Pharmaceutical Manufacturing titled Streamlining Your Serialization Rollout. In the article, Howe lays out the three-stage deployment strategy that ensures compliance with regulatory requirements. Project initiation Configuration and validation Go-live solution hand off In addition, he...

This month in Pharmaceutical Manufacturing and Packing Sourcer, Verify Brand's CEO, Michael Howe, addresses how EU FMD compliance not only provides health and safety benefits to patients, it also presents an opportunity to collect data, improve business processes and create a smarter supply chain. In the article,...

Verify Brand was recently mentioned in a Pharmaceutical Commerce article, “Blockchain technology: the technology to make DSCSA work after 2023?” Nick Basta wrote: “[Robert] Celeste’s work group has attracted a cross-section of industry players—and that has value all by itself since each player has a different...

This month in Outsource Pharma online, Michael Howe, CEO of Verify Brand, a Minneapolis-based serialization software provider, addresses that even though the DSCSA deadline was extended, many pharma manufacturers, such as Verify Brand's client Covis Pharma, are moving forward with their serialization projects. Howe mentions...

Earlier this month, Verify Brand contributed a byline to Pharmaceutical Commerce about the importance of standards. We recently announced that Verify Brand made platform enhancements to the existing functionality of our software’s GS1 EPCIS 1.2 standards for the secure and effective exchange of critical data across the...

This month in Contract Pharma online, Verify Brand’s CEO, Michael Howe, addresses how pharma organizations can successfully -- and quickly -- chose a serialization partner that will help them comply with DSCSA regulations without sacrificing quality. With the clock ticking down on DSCSA compliance deadlines, Howe focuses on the...

Translate »